EMS-Chemie stock holds gains after strong half-year 2026 figures

Published on 09/20/2026 at 15:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EMS-Chemie stock was quoted around CHF 802.50 on SIX Swiss Exchange on September 18, 2026, showing a 0.9 percent pullback after a strong run. Half-year 2026 revenue and earnings rose versus the prior year, underpinning the valuation despite short-term profit-taking.

Chemiewerk in den Alpen, symbolisch für EMS-Chemie Holding AG — Fotorealistische Ansicht einer Chemieanlage symbolisiert EMS-Chemie Holding AG mit ISIN CH0016440353 in Alpenlandschaft, Illustration mit AI erstellt.

EMS-Chemie Holding AG stock (ISIN CH0016440353) traded around CHF 802.50 on SIX Swiss Exchange on September 18, 2026, about 0.9 percent below the previous day’s close as investors took profits after a strong rally in recent weeks, while solid half-year 2026 figures continued to support the story.

Half-year 2026 results underpin EMS-Chemie stock

According to Ad-hoc-news on September 19, 2026, EMS-Chemie reported clearly higher revenue and earnings for the first half of 2026 compared with the prior-year period, giving investors confidence that the group’s specialty polymers and performance materials strategy is paying off.

The same overview from Ad-hoc-news highlights that EMS-Chemie’s half-year 2026 operating result improved versus the first half of 2025, with margins holding up despite cost inflation, which helps explain why the stock remains near the upper end of its 52-week trading range.

Price level and market capitalization as of mid-September 2026

On September 18, 2026, EMS-Chemie stock was quoted at CHF 802.50 on SIX Swiss Exchange at around 12:28 local time, marking an intraday decline of roughly 0.9 percent compared with the prior close, as short-term traders locked in gains after the strong run.

Per the same data snapshot on September 18, 2026, the company’s market capitalization stood near CHF 14,000,000,000, underlining that EMS-Chemie ranks among the larger Swiss specialty chemicals names and that the improved half-year 2026 earnings profile is already reflected in a sizable equity valuation.

Stock perspective for investors

For medium-term investors, the key takeaway is that EMS-Chemie stock remains supported by rising half-year 2026 revenue and earnings versus the prior year, even as the CHF 802.50 quote on September 18, 2026, shows a modest 0.9 percent pullback that looks more like technical consolidation than a fundamental setback.